摘要
本文从多巴胺受体激动剂的分类、作用机制和临床应用等方面综述多巴胺受体激动剂在延缓和治疗帕金森病相关运动并发症中的价值。
The value of dopamine agonists in the postponement and treatment of Parkinson＇s disease-related motor complications is reviewed by referring to recent literature, and the classification of dopamine agonists and their mechanism of action and clinical application in the treatment of Parkinson＇s disease are summarized, which indicates that dopamine agonists can delay the development of motor complications in Parkinson＇s disease.
出处
《上海医药》
CAS
2015年第3期3-8,共6页
Shanghai Medical & Pharmaceutical Journal
基金
上海市科学技术委员会生物医药处重点项目:多巴丝肼胶囊治疗帕金森病的临床研究(项目编号:11DZ1920902
11DZ1920903)
